awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38798623-8CDA9480-089D-467B-BC6C-80BE5B53728B
Q38798623-8CDA9480-089D-467B-BC6C-80BE5B53728B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798623-8CDA9480-089D-467B-BC6C-80BE5B53728B
Implications of the EMPA-REG Trial for Clinical Care and Research.
P2860
Q38798623-8CDA9480-089D-467B-BC6C-80BE5B53728B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798623-8CDA9480-089D-467B-BC6C-80BE5B53728B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b4c6a2f6d52cae7a3aff01a0a75a0a1e7879b22
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.